fashion -WSS

fashion

author：leisure time 2025-08-19 20:45:25 - browse：412

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

knowledge

WSS

Another man arrested in connection with shooting at Kansas nightclub

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Trump seeks lengthy delay of classified docs trial, citing upcoming election

All of Us, NIH's precision medicine initiative, gets a big boost

All of Us, NIH's precision medicine initiative, gets a big boost

Travis Kelce and the trap of celebrity vaccine endorsements

hotspot

fashion

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UPS workers' union leader explains what's at stake as strike edges closer

The cancer drug shortage isn’t new — and neither are the solutions

Kidney transplant patients stopped immunosuppressants in trial

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Coloradans with cystic fibrosis could lose access to Trikafta

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

hotspot

What to know about a major upcoming Wegovy heart health study

House panel to mark up pandemic

Life sciences investors close nearly $6 billion in new funds

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Another man arrested in connection with shooting at Kansas nightclub

Titanic submersible: What a 'catastrophic implosion' means and what officials found

focus

knowledge

entertainment

entertainment